Nemera extends manufacturing capabilities in North America
With a newly acquired space in Vernon Hills, Nemera opens a third location in the United States, in addition to the manufacturing facility in Buffalo Grove and Innovation center in Chicago.
Nemera reinforces commitment to sustainability with first integrated ESG report
Designed as a snapshot of work over the years and a look into the future, the first ESG report is a new and important step forward in our sustainability journey as a company.
Brand new state-of-the-art Nemera manufacturing facility inaugurated in Poland
Based in Szczecin, this facility will significantly boost Nemera’s manufacturing capabilities and bring more drug delivery device solutions to patients.
Nemera to build state-of-the-art manufacturing facility in Poland to serve more customers and patients
Based in Szczecin, this facility extends Nemera’s manufacturing capabilities and will bring more drug delivery device solutions to patients.
Nemera reinforces its value proposition with a refreshing visual identity
More modern, our new brand identity truly embodies who we are, how we partner with our customers and ultimately the value we bring to millions of patients across the world through...
Nemera has won the Pharmapack Award in the “Connected Devices and Wearables” category with its body injector platform SYmbioze
Symbioze, the smart, high volume and sustainable on-body injector platform developed by Nemera, wins the ‘Connected Devices and Wearables’ Award at Pharmapack 2021
Nemera joins IPAC-RS as an Associate Member
Nemera is excited to announce that it has become an Associate Member of the International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS). Nemera’s decision to...
Nemera launches UniSpray, its unidose system primarily for systemic-acting drug administration.
Nemera has a proven track record in developing and manufacturing complex Ear Nose and Throat solutions. In line with clear growing market interest in unidose system coupled with...
Nemera breaks ground in Brazil through Milfra acquisition
its overall commitment to serving local markets. By integrating a key applicator pure player, Nemera will now be able to address specific patient and customer needs in the fields...
Nemera and BIOMM sign partnership agreementto commercialize reusable insulin pen in Brazil
This partnership expands offer of diabetes medicines in the country; Nemera’s Advapen launch happens under the trade name Lifepen® for the administration of Glargilin insulin for...
Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations
Nemera is excited to announce that its multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON [1] (Ketorolac 0,4% and 0,5%),...
Nemera and Noble announce collaboration to support patients who self-administer medication
Nemera is excited to leverage the new collaboration to expand end-to-end offering of the parenteral franchise and increase patient onboarding through safer multi-use training devices
Safe’n’Spray, the smart electronic concept device with child-resistant and locking features, wins the ‘Best Innovation In Drug Delivery Device’ award at Pharmapack 2020
A team of industry experts awarded Nemera’s Safe’n’Spray with a prestigious Pharmapack Award for ‘Best Innovation in Drug Delivery Device’.
A first launch on OTC drugs with Advancia!
A first launch on OTC drugs with Advancia!
Nemera acquires Insight Product Development to strengthen its capabilities in early stage development and to reinforce client proximity in North America.
We are pleased to announce that Nemera has completed the acquisition of Insight Product Development, a 100% healthcare focused design and innovation consulting firm based in Chicago,...
Nemera announces a better drug deposition with RetroNose to enhance therapeutic efficacy of nasal treatments
After announcing a partnership with the Research Center for Respiratory Diseases (CEPR) of Inserm/University of Tours in April 2017, Nemera is happy to publish enhanced drug...
Nemera lay the first brick of a new manufacturing building
Yesterday, in the presence of numerous guests, the new project partners NEMERA and NOVO NORDISK laid the foundation stone for a new manufacturing Hall. The new building will be...
Nemera’s preservative-free multidose eye dropper Novelia approved for Santen’s Cosop, for Glaucoma treatments in 29 European countries
Santen announced that the preservative-free formulation Cosopt iMulti® will launch in 29 European countries in the coming months.
Nemera’s Innovation Center reaches 100 employees
Nemera’s celebrated an important milestone: its Innovation Center has just hired its 100th employee.
Nemera organised an expert review on the present and future of inhalation products
The e-Novelia ophthalmic add-on developed by Nemera wins the ‘Excellence in Pharma: Drug Delivery Devices’ Award at CPhI Worldwide 2018
A team of industry experts awarded Nemera’s electronic add-on for ophthalmic droppers with a prestigious CPhI Award for Best Drug Delivery Device in its category
Nemera receives drug manufacturing authorisation for its Neuenburg plant in Germany
Important achievement for Nemera, now able to handle, assemble, sterilize and store pharmaceutical drugs and medicinal products for autoinjectors.
Nemera has won the ‘Editor’s choice’ category at the annual INTERPHEX Awards, for its 2 steps-autoinjector Safelia
INTERPHEX and a team of industry experts select Nemera (booth 1636) as winner for this year’s exhibitor awards as Editor’s choice.
The Safelia autoinjector developed by Nemera wins the 'Exhibitor innovation' award at Pharmapack
A team of industry experts reward Nemera's autoinjector with a Pharmapack Award as best innovation product.
